News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
EMSTER KURT VON
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2020 |
4/A
| EMSTER KURT VON (Director) has filed a Form 4 on Vaxcyte, Inc.|
Txns:
| Granted 40,000 options to buy
@ $16, valued at
$640k
|
|
| 01/18/2019 |
4/A
| EMSTER KURT VON (Director) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 62,925 shares
@ $29.7047, valued at
$1.9M
|
|
| 06/11/2018 |
4/A
| EMSTER KURT VON (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold 920 shares
@ $12.51, valued at
$11.5k
Exercised (in-or-at-the-money) 2,000 warrants
@ $5.75, valued at
$11.5k
|
|
| 06/07/2018 |
4/A
| EMSTER KURT VON (Director) has filed a Form 4 on CRISPR Therapeutics AG |
| 02/16/2018 |
4/A
| EMSTER KURT VON (Director) has filed a Form 4 on CymaBay Therapeutics, Inc.|
Txns:
| Sold 162,979 shares
@ $13.69, valued at
$2.2M
|
|
| 08/11/2017 |
4/A
| EMSTER KURT VON (Director) has filed a Form 4 on CRISPR Therapeutics AG |
| 07/14/2009 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
|
|